C12N 2720/12243
Viral genome or elements thereof as genetic vector
Official title: viral genome or elements thereof as genetic vector
C12N2720/12243 (Viral genome or elements thereof as genetic vector) appears on 7 US grants and 10 published applications in this corpus.
Search patents in C12N- Granted patents
- 7
- Published applications
- 10
- Assignees
- 5
- Inventors
- 9
- Latest grant
- 2 Feb 2016
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 0 | 1 |
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 1 | 1 |
| 2007 | 0 | 0 |
| 2008 | 1 | 2 |
| 2009 | 0 | 0 |
| 2010 | 1 | 1 |
| 2011 | 0 | 0 |
| 2012 | 2 | 2 |
| 2013 | 1 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 0 |
By publication year.
Recent patents
- Reovirus vaccines and methods of use therefor2 Feb 2016US 9,249,195 B2Vanderbilt University
- Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions20 Aug 2013US 8,512,712 B2Oncolytics Biotech Inc.
- System for generation of viable reovirus from cloned cDNA23 Oct 2012US 8,293,498 B2Vanderbilt University
- Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions3 Apr 2012US 8,147,845 B2Oncolytics Biotech Inc.
- Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions1 Jun 2010US 7,727,534 B2Oncolytics Biotech Inc.
- Reovirus vaccines and methods of use therefor3 Oct 2013US 2013/0259887 A1Vanderbilt University
- Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions6 Sep 2012US 2012/0225045 A1Oncolytics Biotech Inc.
- System for generation of viable reovirus from cloned cdna7 Jun 2012US 2012/0142078 A1Vanderbilt University
- Reovirus Clearance of Ras-Mediated Neoplastic Cells from Mixed Cellular Compositions30 Sep 2010US 2010/0248205 A1Oncolytics Biotech Inc.
- Virus clearance of neoplastic cells from mixed cellular compositions14 Feb 2008US 2008/0038822 A1Oncolytics Biotech Inc.
Most cited
By later US patents
- Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions13US 6,994,858 B2Oncolytics Biotech Inc. · 2006
- Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions9US 7,431,932 B2Oncolytics Biotech Inc. · 2008
- System for generation of viable reovirus from cloned cDNA1US 8,293,498 B2Vanderbilt University · 2012